TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

12.70$ +1.4% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow INKT
Line item 2019 2020 2021 2022 2023 2024 2025
-2,167.0% – – -0.7% – – –
5.3% – – 0.0% – – –
31.8% – – 0.1% – – –
184.5% – – 0.1% – – –
596.7% – – 0.3% – – –
61.8% – – 0.0% – – –
-61.8% – – 0.0% – – –
– – – 0.0% – – –
1,658.3% – – 0.0% – – –
1,658.3% – – 0.0% – – –
-588.3% – – -0.7% – – –
-2,228.9% – – -0.7% – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?